Press release
03.11.2017 To the attention of interested persons Review of flupirtine-containing medicines started. download document …
Press release
01.11.2017 To the attention of interested persons EMA starts new review of hydroxyethyl-starch containing medicines. download document …
Press release
01.11.2017 To the attention of interested persons PRAC recommends further restrictions for multiple sclerosis medicine Zinbryta due to risk of […]
Press release
30.10.2017 To the attention of interested persons NAMMD position in response to recent press allegations The National Agency for Medicines […]
Important notification
17.10.2017 To the attention of interested persons Information for sponsors of clinical trials regarding the electronic submission of SUSARs to […]
Important notification
17.10.2017 To the attention of interested persons Information for marketing authorization holders (MAHs) regarding alternative arrangements for electronic submission of […]
Important notification
17.10.2017 To the attention of interested persons The NAMMD would like to inform about the organization in Romania of a […]
Press release
10.10.2017 To the attention of interested persons Countdown to launch of new EudraVigilance System: final preparations for change-over to new […]
Press release
06.10.2017 To the attention of interested persons EMA press release: PRAC recommends modified-release paracetamol be removed from market (update: 29 […]
Press release
25.09.2017 To the attention of interested persons EMA concludes review of human factor VIII medicines authorised in EU download document […]